Drug Type CAR-T |
Synonyms |
Target |
Mechanism CD276 inhibitors(CD276 antigen inhibitors), caspase 9 inhibitors(Caspase-9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Ductal Adenocarcinoma | Preclinical | US | 22 Mar 2024 | |
Uveal Melanoma | Preclinical | US | 02 Nov 2023 |